Davis PJ, Davis FB, Lin HY, Mousa SA, Zhou M, Luidens MK.Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor. Am J Physiol Endocrinol Metab. 2009; 297(6):E1238-46. Bharali DJ, Khalil M, Gurbuz M, Simone TM, Mousa SA. Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers. Int J Nanomedicine. 2009; 4(1):1-7. Arias HR, Richards VE, Ng D, Ghafoori ME, Le V, Mousa SA. Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis. Int J Biochem Cell Biol. 2009; 41(7):1441-51.
SPONSOR/GRANT TITLE: University of Wisconsin-DOD SubAward-Sustained Release Oral Nanoformulated Green Tea for Prostate Cancer Prevention TERM: 04/15/10-04/14/11 TOTAL GRANT: $40,501.00 SPONSOR/GRANT TITLE: NIH/Site-directed Chemotherapy for Breast Cancer Using Novel Angiogenesis Inhibitor TERM: 08/07/09-07/31/11 TOTAL GRANT: $372,680.00
Aljada A, Shah KA, Mousa SA. Peroxisome proliferatoractivated receptor agonists: do they increase cardiovascular risk? PPAR Res. 2009; 2009:460-764.
Dept. of Health Sciences PUBLICATIONS
Barone C, Mousa SS, Mousa SA. Pharmacoenomics in cardiovascular disorders: Steps in approaching personalized medicine in cardiovascular medicine. Pharmacogenomics and Personalized Medicine 2009:2: 1-9.
Magdalene Assimon Assimon, MM, Salenger, PV, El-Fawal, HAN, Mason, DL. Characterization of Ergocalciferol supplementation on vascular adhesion molecules and oxidative LDL in hemodialysis patients. Am. J. Nephrology (submitted). (2010).
Greene R, Mousa SS, Ardawi M, Qari M, Mousa SA. Pharmacogenomics in osteoporosis: Steps toward personalized medicine. Pharmacogenomics and Personalized Medicine 2009:2 1-10. Clarke H, Mousa SA. The implications of pharmacogenomics in the treatment of HIV-1-infected patients of African descent. Pharmacogenomics and Personalized Medicine 2009:2 93-99. Avery P, Mousa SS, Mousa SA. Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine. Pharmacogenomics and Personalized Medicine 2009:2 1-13.
GRANTS Shaker Mousa SPONSOR/GRANT TITLE: RPI NIH Sub Award- Development of Biengineered Heparin From a NonAnimal Source TERM: 08/01/09-04/30/14 TOTAL GRANT: $654,500.00 SPONSOR/GRANT TITLE: Vascular Vision Pharmaceutcials-Novel Modulators of HDL Metabolism TERM: 07/27/09-07/26/10 TOTAL GRANT: $75,000.00
Indra Balachandran Balachandran I, Walker J, Taylor J, et al: The impact of New York State’s new licensure legislation for laboratory professionals on health care providers: Results of a survey on issues related to staffing of clinical laboratories, Journal of Allied Health, Dec 2009, 113E-117E. Balachandran I. Transformation in Education and Practice: Cytotechnology Program, Albany College of Pharmacy & Health Sciences, Albany, N.Y. ASC Bulletin, 2010, XLVII (4): 94-95. Balachandran I, Walker J, Broman J: Fine Needle Aspiration Cytology of ALK 1(-), CD 30(+) Anaplastic Large Cell Lymphoma Post Renal Transplantation – A Case Report and literature review. Diagnostic Cytopathology, 2009 doi:10.1002/dc21176. Balachandran I, Jiayuh Ju, Walker J, Broman J: Fine needle aspiration of metastatic granulosa cell tumor of the ovary. Accepted for publication in Acta Cytologica, Feb. 2010.
Lawrence Lansing Yalcin M, Bharali DJ, Dyskin E, Dier E, Lansing L, Mousa SS, Davis FB, Davis PJ, Mousa SA. Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma. Thyroid. 2010 Mar;20(3):281-6. Yalcin M, Dyskin E, Lansing L, Bharali DJ, Mousa SS, Bridoux A, Hercbergs AH, Lin HY, Davis FB, Glinsky GV, Glinskii A, Ma J, Davis PJ, Mousa SA. Tetraiodothyroacetic Acid (Tetrac) and Nanoparticulate Tetrac Arrest Growth of Medullary Carcinoma of the Thyroid. J Clin Endocrinol Metab. 2010 Feb 4. [Epub ahead of print] Yalcin M, Bharali DJ, Lansing L, Dyskin E, Mousa SS, Hercbergs A, Davis FB, Davis PJ, Mousa SA. Tetraiodothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts. Anticancer Res. 2009 Oct; 29(10):3825-31.
ARTICLE REVIEWS Lawrence Lansing Davis PJ, Zhou M, Davis FB, Lansing L, Mousa SA, Lin HY. Mini-review: Cell surface receptor for thyroid hormone and nongenomic regulation of ion fluxes in excitable cells. Physiol Behav. 2010 Feb 9;99(2):237-9.
BOOK CHAPTERS Hassan El-Fawal El-Fawal, H.A.N. Neurotoxicity: Common themes and biomarkers. Encyclopedia of Environmental Health. (S. Ansar, ed). Elseviers Publishing, London, UK. (in press for 2010).
ABSTRACTS/PRESENTATIONS & EXHIBITS Indra Balachandran Balachandran I., Walker J. “Development of an Asynchronous Review Course in Cytopathology.” Faculty Development Series, Albany College of Pharmacy and Health Sciences, March 30, 2010.
Bolded names within citations indicate ACPHS faculty collaborators.
51